Nektar Therapeutics
NKTR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,078 | $364 | $143 | $195 |
| - Cash | $41 | $43 | $39 | $44 |
| + Debt | $92 | $96 | $100 | $103 |
| Enterprise Value | $1,129 | $417 | $205 | $253 |
| Revenue | $12 | $11 | $10 | $29 |
| % Growth | 5.5% | 6.8% | -64.1% | – |
| Gross Profit | $12 | $11 | $10 | $21 |
| % Margin | 100% | 100% | 100% | 72.7% |
| EBITDA | -$29 | -$34 | -$41 | $17 |
| % Margin | -248.6% | -302.3% | -391.7% | 59.9% |
| Net Income | -$36 | -$42 | -$51 | $7 |
| % Margin | -301.3% | -372.2% | -486.4% | 24.9% |
| EPS Diluted | -1.87 | -2.95 | -3.62 | 0.51 |
| % Growth | 36.6% | 18.5% | -809.8% | – |
| Operating Cash Flow | -$49 | -$46 | -$49 | -$46 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$49 | -$46 | -$49 | -$47 |